Crinetics Pharmaceuticals
Crinetics Pharmaceuticals is a United States-based biotechnology company running 3 late-stage cancer trials of CRN09682 in neuroendocrine tumours and pancreatic ductal adenocarcinoma.
Overview
Crinetics Pharmaceuticals, based in San Diego, the United States, is a biotechnology company and part of Vertex Pharmaceuticals. Crinetics Pharmaceuticals is an endocrinology-focused pharmaceutical company that develops therapies for endocrine diseases and endocrine-related tumours. On ClinicalTrials.gov it is the lead sponsor of 3 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing CRN09682 in neuroendocrine tumours and pancreatic ductal adenocarcinoma. The largest, NCT07129252 (A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumours), plans to enrol 150 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanySinotau Pharmaceutical
Shares Neuroendocrine tumours and the tag ctgov-sponsor.
- CompanyCEBIOTEX
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyMolecular Partners
Shares Neuroendocrine tumours, Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyCivaTech Oncology
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyAscentawits Pharmaceuticals
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyOrion, Orion Pharma
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyOncolytics Biotech
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.
- CompanyMBrace Therapeutics
Shares Pancreatic ductal adenocarcinoma and the tag ctgov-sponsor.